Emcure Pharmaceutical Receive Sebi nod for its IPO Launch
Emcure Pharmaceuticals today received market regulator Securities and Exchange Board of India (SEBI) nod for its IPO launch. The company had filed its Draft Red Herring Prospectus with the market regulator in December 2023, the IPO comprises a fresh issuance of equity shares worth Rs 800cr and an offer of sale of 1.36 crore equity shares by promoters and existing shareholders, Proceeds of the fresh issue will be used towards payment of debt and for general corporate purposes.
Tags
Stay Connected, Stay Informed –
Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.
Pre Ipo
Upcoming IPO
Unicorn
Planify Enterprises Private Limited
Planify Capital Limited
Licensed By
Registrations & Certifications
Mutual Fund License No.:
ARN-164419
IRDA Code (1):
ABLIC1003123454
IRDA Code (2):
ABLIC1003131639
Startup India Certificate No.:
DIPP93786
Other Websites
Address
MiQB, Plot 23, Sector 18 Maruti, Industrial Development Area, near Motherson Sumi Systems Limited, Gurugram, Haryana 122015
ⓒ 2016-2026 Planify. All rights reserved, Built with
in India
